In all, these results show that ablation of VLA4 through deletion of the ITGA4 (α4) subunit impairs myeloma cell homing and dissemination in the bone, prolonging survival and reducing osteolysis. The gene discussed is ITGA4; the disease is plasma cell myeloma.